TALTZ sol inj 80 mg/ml stylo pré (s citrate) 1 ml

7680659070031 CH-65907 L04AC13 07.15.0.

Active substances:

TALTZ sol inj 80 mg/ml stylo pré (s citrate) 1 ml
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6590701
CPT
-
Packaging group
1
Unit
Injektor(en), vorgefüllt/Pen
Composition
ixekizumabum 80 mg, saccharum, polysorbatum 80, natrii hydroxidum q.s. ad pH, aqua ad iniectabile, ad solutionem pro 1 ml.

Articles (1)

Taltz 80 mg, solution injectable en stylo prérempli
Lösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
21/04/2026
Patient information leaflet
Français
21/04/2026
Patient information leaflet
Italien
21/04/2026

Detailed composition

Substance Quantity Type Category
ixekizumabum
80.0 MG Substance Wirkstoff (Principe actif)
saccharum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
natrii hydroxidum
- Substance HBESI
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 1015.50
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2023

Authorization holder

Eli Lilly (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
65907
Drug name
Taltz, solution injectable en stylo prérempli
Galenic form
INLFP
ATC Code
L04AC13
Authorization status
Z
Dispensation category
B
First authorization
12/12/2016
Authorization expiration date
31/12/9999
IT number
07.15.0.
Domain
Human medicine
Field of application
Plaque-Psoriasis bei Erwachsenen, Psoriasis-Arthritis, Plaque-Psoriasis bei Kindern und Jugendlichen ab 6 Jahren mit einem Körpergewicht von mindestens 25 kg, Ankylosierende Spondylitis, Nicht-radiographische axiale Spondyloarthritis

Packaging details

Description (FR)
TALTZ sol inj 80 mg/ml stylo pré (s citrate) 1 ml
Description (DE)
TALTZ Inj Lös 80 mg/ml Fertigpen (citratfrei) 1 ml
Market launch
12/12/2016
Narcotic (BTM)
No

Other packaging sizes

Buy us a coffee Explore the data